Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-917. 10.1002/ijc.25516.
Article
CAS
PubMed
Google Scholar
Gandara D, Narayan S, Lara PN, Goldberg Z, Davies A, Lau DH, Mack P, Gumerlock P, Vijayakumar S: Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer. Clin Cancer Res. 2005, 11: 5057s-5062s. 10.1158/1078-0432.CCR-05-9012.
Article
CAS
PubMed
Google Scholar
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.
Article
PubMed
Google Scholar
Naruke T, Tsuchiya R, Kondo H, Asamura H: Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg. 2001, 71: 1759-1764. 10.1016/S0003-4975(00)02609-6.
Article
CAS
PubMed
Google Scholar
Aggarwal BB: Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003, 3: 745-756. 10.1038/nri1184.
Article
CAS
PubMed
Google Scholar
Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G: Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization. Br J Cancer. 2000, 83: 480-486. 10.1054/bjoc.2000.1345.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boldrini L, Gisfredi S, Ursino S, Lucchi M, Melfi F, Mussi A, Basolo F, Fontanini G: Tumour necrosis factor-alpha: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer. Int J Mol Med. 2006, 17: 887-892.
CAS
PubMed
Google Scholar
Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR: Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer. 1994, 56: 777-782. 10.1002/ijc.2910560603.
Article
CAS
PubMed
Google Scholar
Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR: Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest. 1993, 91: 2194-2206. 10.1172/JCI116446.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tran TA, Kallakury BV, Ambros RA, Ross JS: Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer. 1998, 83: 276-282. 10.1002/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, Ichikawa Y, Endo I, Kunisaki C, Suzuki H, Hayasizaki Y, et al: Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer. 2006, 119: 406-413. 10.1002/ijc.21843.
Article
CAS
PubMed
Google Scholar
Su C, Zhou C, Zhou S, Xu J: Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Med Oncol. 2010
Google Scholar
Rube CE, Wilfert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rube C: Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol. 2002, 64: 177-187. 10.1016/S0167-8140(02)00077-4.
Article
CAS
PubMed
Google Scholar
Zhang M, Qian J, Xing X, Kong FM, Zhao L, Chen M, Lawrence TS: Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Clin Cancer Res. 2008, 14: 1868-1876. 10.1158/1078-0432.CCR-07-1894.
Article
CAS
PubMed
Google Scholar
Hajeer AH, Hutchinson IV: Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 2001, 62: 1191-1199. 10.1016/S0198-8859(01)00322-6.
Article
CAS
PubMed
Google Scholar
Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, Toyota T: Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology. 1999, 117: 1062-1068. 10.1016/S0016-5085(99)70390-2.
Article
CAS
PubMed
Google Scholar
Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A: Genetic influence on cytokine production in meningococcal disease. Lancet. 1997, 349: 1912-1913. 10.1016/S0140-6736(05)63910-4.
Article
CAS
PubMed
Google Scholar
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997, 94: 3195-3199. 10.1073/pnas.94.7.3195.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beltinger CP, White PS, Maris JM, Sulman EP, Jensen SJ, LePaslier D, Stallard BJ, Goeddel DV, de Sauvage FJ, Brodeur GM: Physical mapping and genomic structure of the human TNFR2 gene. Genomics. 1996, 35: 94-100. 10.1006/geno.1996.0327.
Article
CAS
PubMed
Google Scholar
Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, Arinobu Y, Otsuka T, Sawabe T, Harashima S, Nagasawa K, et al: Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum. 2001, 44: 2819-2827. 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2.
Article
CAS
PubMed
Google Scholar
Bayley JP, Ottenhoff TH, Verweij CL: Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004, 5: 315-329. 10.1038/sj.gene.6364055.
Article
CAS
PubMed
Google Scholar
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, et al: Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007, 121: 483-490. 10.1007/s00439-006-0315-x.
Article
CAS
PubMed
Google Scholar
Hajeer AH, Hutchinson IV: TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000, 50: 216-228. 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE: Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer. 1998, 77: 2246-2251. 10.1038/bjc.1998.373.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY: Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006, 52: 15-20. 10.1016/j.lungcan.2005.11.011.
Article
PubMed
Google Scholar
Mestiri S, Bouaouina N, Ben Ahmed S, Chouchane L: A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma. Cytokine. 2005, 30: 182-187. 10.1016/j.cyto.2005.01.007.
Article
CAS
PubMed
Google Scholar
Stankovic MM, Nestorovic AR, Tomovic AM, Petrovic-Stanojevic ND, Andjelic-Jelic MS, Dopudja-Pantic VB, Nagorni-Obradovic Lj M, Mitic-Milikic MM, Radojkovic DP: TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma. 2009, 56: 348-352. 10.4149/neo_2009_04_348.
Article
CAS
PubMed
Google Scholar
Ahirwar DK, Mandhani A, Dharaskar A, Kesarwani P, Mittal RD: Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy. BJU Int. 2009, 104: 867-873. 10.1111/j.1464-410X.2009.08549.x.
Article
CAS
PubMed
Google Scholar
Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ: Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology. 2005, 65: 70-75. 10.1016/j.urology.2004.08.005.
Article
PubMed
Google Scholar
Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH: The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001, 166: 41-46. 10.1016/S0304-3835(01)00438-4.
Article
CAS
PubMed
Google Scholar
Yapijakis C, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Vassiliou S, Avgoustidis D, Neukam FW, Patsouris E, Vairaktaris E: Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. Anticancer Res. 2009, 29: 2379-2386.
CAS
PubMed
Google Scholar
Gupta R, Sharma SC, Das SN: Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol. 2008, 44: 455-463. 10.1016/j.oraloncology.2007.06.003.
Article
CAS
PubMed
Google Scholar
Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, et al: A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 2003, 125: 364-371. 10.1016/S0016-5085(03)00899-0.
Article
CAS
PubMed
Google Scholar
Fang F, Yao L, Yu XJ, Yu L, Wu Q: TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat. 122: 267-271.
Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ: Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. Urology. 2004, 64: 1052-1056. 10.1016/j.urology.2004.06.018.
Article
PubMed
Google Scholar
Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, Jrad BB, Remadi S, Chouchane L: Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer. 2001, 91: 672-678. 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J.
Article
CAS
PubMed
Google Scholar
Kladny J, Suchy J, Klujszo-Grabowska E, Kacperski T, Scott RJ, Kurzawski G, Lubinski J: Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. Cancer Epidemiol. 2009, 33: 161-163. 10.1016/j.canep.2009.06.004.
Article
CAS
PubMed
Google Scholar
Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, et al: Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol. 2009, 27: 3370-3378. 10.1200/JCO.2008.20.6763.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu Z, Taylor JA: SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009, 37: W600-605. 10.1093/nar/gkp290.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greene FL: The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg. 2002, 87: 13-15.
PubMed
Google Scholar
Das SN, Baniasadi V, Kapuria V: Association of -308 TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. Int J Immunogenet. 2006, 33: 411-416. 10.1111/j.1744-313X.2006.00632.x.
Article
CAS
PubMed
Google Scholar
Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M, Folwaczny C: Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol. 2004, 22: 4746-4752. 10.1200/JCO.2004.03.034.
Article
CAS
PubMed
Google Scholar
Sharma R, Zucknick M, London R, Kacevska M, Liddle C, Clarke SJ: Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer. 2008, 7: 331-337. 10.3816/CCC.2008.n.044.
Article
CAS
PubMed
Google Scholar
Hohaus S, Giachelia M, Di Febo A, Martini M, Massini G, Vannata B, D'Alo F, Guidi F, Greco M, Pierconti F, et al: Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Ann Oncol. 2007, 18: 1376-1381. 10.1093/annonc/mdm132.
Article
CAS
PubMed
Google Scholar
Smith KC, Bateman AC, Fussell HM, Howell WM: Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet. 2004, 31: 167-173. 10.1111/j.1365-2370.2004.00462.x.
Article
CAS
PubMed
Google Scholar
Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem. 1993, 268: 18542-18548.
CAS
PubMed
Google Scholar
Stark GL, Dickinson AM, Jackson GH, Taylor PR, Proctor SJ, Middleton PG: Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation. 2003, 76: 1742-1749. 10.1097/01.TP.0000092496.05951.D5.
Article
CAS
PubMed
Google Scholar
Till A, Rosenstiel P, Krippner-Heidenreich A, Mascheretti-Croucher S, Croucher PJ, Schafer H, Scheurich P, Seegert D, Schreiber S: The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. J Biol Chem. 2005, 280: 5994-6004.
Article
CAS
PubMed
Google Scholar
Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T: TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2010, 29: 100-10.1186/1756-9966-29-100.
Article
PubMed
PubMed Central
Google Scholar
Sainz J, Pérez E, Hassan L, Moratalla A, Romero A, Collado MD, Jurado M: Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum Immunol. 2007, 68: 41-50. 10.1016/j.humimm.2006.10.011.
Article
CAS
PubMed
Google Scholar